| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/25/2009 | CN101395156A Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
| 03/25/2009 | CN101395155A Pyridopyrimidinone inhibitors of pi3k alpha |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/24/2009 | US7507860 Androgen modulators |
| 03/24/2009 | US7507826 Such as 3-(2-Methanesulfonyl-pyrimidin-4-yl)-5-pyridin-3-yl-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine; heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, hypertension, allergic diseases, autoimmune diseases, destructive bone disorders |
| 03/24/2009 | US7507824 Spiro(2H-1benzopyran-2,4′-piperidine) derivates as glycine transport inhibitors |
| 03/24/2009 | US7507822 Cyclizing, halogenating by reacting in presence of catalytic amount of metal halide and dehydrating agent |
| 03/24/2009 | US7507751 Biphenyl derivatives |
| 03/24/2009 | US7507746 Enantiomer of tenatoprazole and the use thereof in therapy |
| 03/24/2009 | US7507741 Heterocyclic compounds |
| 03/24/2009 | US7507398 Using condensation aerosol (MMAD of less than 5 microns) formed by vaporizing a thin layer of the drug on a solid support and condensing the vapor to treat anxiety, vertigo, alcohol or nicotine withdrawal, sedation, hot flashes, peptic ulcers or for hormone replacement therapy, or pregnancy prevention |
| 03/24/2009 | US7507397 Delivery of muscle relaxants through an inhalation route |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/19/2009 | WO2009036412A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/19/2009 | WO2009035652A1 Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
| 03/19/2009 | WO2009035575A1 Inhibitors of janus kinases |
| 03/19/2009 | WO2009035568A1 Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling |
| 03/19/2009 | WO2009034976A1 Alkylsulfone derivative |
| 03/19/2009 | WO2009034475A2 Perharidines as cdk inhibitors |
| 03/19/2009 | WO2009034411A1 Perharidines as cdk inhibitors |
| 03/19/2009 | WO2009034029A2 1-substituted 4-heterocyclylpiperidines for use as cgrp antagonists |
| 03/19/2009 | WO2009034028A2 Novel compounds |
| 03/19/2009 | WO2009033360A1 Benzamide derivatives, their preparation and uses in medicine thereof |
| 03/19/2009 | WO2009014637A3 Heterocyclic amide compounds as protein kinase inhibitors |
| 03/19/2009 | WO2009013299A3 Novel bradykinin b1 antagonists |
| 03/19/2009 | WO2009007536A3 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 03/19/2009 | WO2009003669A3 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 03/19/2009 | WO2008153793A3 Gamma secretase modulators |
| 03/19/2009 | WO2008138878A3 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof |
| 03/19/2009 | WO2008104306A3 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof |
| 03/19/2009 | WO2008024415A3 Process for the synthesis of cmhtp and intermediates thereof |
| 03/19/2009 | WO2008005511A8 Novel inhibitors of hepatitis c virus replication |
| 03/19/2009 | WO2005076861A3 Compounds that inhibit hiv particle formation |
| 03/19/2009 | US20090076275 Diacylglycerol acyltransferase inhibitors |
| 03/19/2009 | US20090076274 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders |
| 03/19/2009 | US20090076069 Deuterium-enriched apixaban |
| 03/19/2009 | US20090076068 Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases |
| 03/19/2009 | US20090076066 Deuterium-enriched zolpidem |
| 03/19/2009 | US20090076065 Deuterium-enriched mk-0812 |
| 03/19/2009 | US20090076064 Compounds |
| 03/19/2009 | US20090076063 Carboxamide compound and use of the same |
| 03/19/2009 | US20090076056 Deuterium-enriched topotecan |
| 03/19/2009 | US20090076055 Deuterium-enriched vinflunine |
| 03/19/2009 | US20090076046 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 03/19/2009 | US20090076015 Tricyclic Spiro Compound Comprising Acyl Group Bound to Nitrogen Atom in the Ring |
| 03/19/2009 | US20090076013 Deuterium-enriched sitagliptin |
| 03/19/2009 | US20090076012 Modulation of pathogenicity |
| 03/19/2009 | US20090075980 Pyrazolopyridines and Analogs Thereof |
| 03/19/2009 | US20090075978 Substituted propiolic acid amides and their use for producing drugs |
| 03/19/2009 | US20090074887 For control of phytopathogenic fungi; synergistic |
| 03/19/2009 | US20090074825 Colorants based n-halamines compositions and method of making and using |
| 03/19/2009 | DE102004022915B4 Indolstyryl-Verbindung zur Verwendung in Aufnahmemedien und Verfahren zu dessen Herstellung Indolstyryl compound for use in recording media and methods for its preparation |
| 03/19/2009 | CA2699382A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/19/2009 | CA2699040A1 Perharidines |
| 03/19/2009 | CA2698808A1 Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
| 03/19/2009 | CA2698371A1 Alkylsulfone derivatives |
| 03/19/2009 | CA2698256A1 Inhibitors of janus kinases |
| 03/19/2009 | CA2697682A1 Annelated pyridazines for the treatment of tumors driven by inapropriate hedgehog signalling |
| 03/18/2009 | EP2036909A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
| 03/18/2009 | EP2036908A2 Efficient synthesis of pyropheophorbide a derivates |
| 03/18/2009 | EP2036907A1 Organic electroluminescence device |
| 03/18/2009 | EP2036906A1 Azaindoles as inhibitors of soluble adenylate cyclase |
| 03/18/2009 | EP2036560A1 (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy |
| 03/18/2009 | EP2035420A2 Kv1.5 potassium channel inhibitors |
| 03/18/2009 | EP2035419A1 5-aryl-substituted dihydropyridopyrimidines and dihydropyridazines and use thereof as mineral corticoid antagonists |
| 03/18/2009 | EP2035412A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 03/18/2009 | EP1658289B1 3-substituted imidazopyridine-derivatives as c-kit inhibitors |
| 03/18/2009 | EP1615921B1 Pyrido 2,3-d pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 03/18/2009 | EP1569936B1 Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments |
| 03/18/2009 | EP1539151B1 Biaryl compounds having anti-infective activity |
| 03/18/2009 | EP1458720B1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 03/18/2009 | EP1389096B1 Delivery of opioids through an inhalation route |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
| 03/18/2009 | CN101389737A Use of polynuclear phenolic compounds as stabilisers |
| 03/18/2009 | CN101389632A Spiroketals |
| 03/18/2009 | CN101389629A Indolopyridines as EG5 kinesin modulators |
| 03/18/2009 | CN101389628A Indolopyridines as EG5 kinesin modulators |
| 03/18/2009 | CN101389627A Antibacterial pyrrolopyridines, pyrrolopyrimidines and pyrroloazepines-154 |
| 03/18/2009 | CN101389626A Fused ring heterocycle kinase modulators |
| 03/18/2009 | CN101389338A 双环杂芳基化合物 Bicyclic heteroaryl compounds |
| 03/18/2009 | CN101386621A Naphthalenetetracarboxylic acid diimide derivative and electrophotographic photoconductor having the same |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/17/2009 | US7504511 e.g. N-[4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4((4-[2-(S)-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agent |
| 03/17/2009 | US7504509 Compounds and methods for development of Ret modulators |
| 03/17/2009 | US7504507 carboxamide linked compounds based on benzo[b][1,6]naphthyridin-1 (2H)-one, which differ from previous acridine based compounds by the incorporation of a lactam or thiolactam function in one of the outer rings |
| 03/17/2009 | US7504506 Therapeutic compounds and uses thereof |
| 03/17/2009 | US7504501 Antiprotozoal imidazopyridine compounds |
| 03/17/2009 | US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists |
| 03/17/2009 | US7504426 Antiallergens; rhitinis; antiinflammatory agents |
| 03/17/2009 | US7504422 Polyamine compounds |
| 03/17/2009 | US7504414 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504406 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
| 03/17/2009 | US7504405 Mitotic kinesin inhibitors |
| 03/17/2009 | US7504403 Substituted heterocyclic compounds and methods of use |
| 03/17/2009 | US7504162 Heat resistance; forming film |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2194064C Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |